Total : 22 View more »
Quidel Corporation (QDEL)Q3 2009 Earnings CallOctober 10, 2009 10:00 am ET<a
http://seekingalpha.com/article/167381-quidel-corporation-q3-earnings-call-transcript?source=feed
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL - News), a leader in point-of-care rapid diagnostic tests, today announced financial results
http://finance.yahoo.com/news/Quidel-Reports-Third-Quarter-bw-1763210549.html?x=0&.v=1
San Diego’s Quidel, which signaled it would report better-than-expected quarterly results on Sept. 10, isn’t the only San Diego biomedical company to get a
Quidel says regulators approve version of QuickVue flu test that can detect swine flu
Total : 39 View more »
Oct 31, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Quidel (NASDAQ:QDEL) on October 19, 2009 at $14.96.
Since then, Quidel has returned 4.5% as of Friday's recent price of $14.28. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq profit securities trial
Companies: QUIDEL Corp. (QDEL)
Oct 19, 2009 (M2 EQUITYBITES via COMTEX) --
Diagnostic tests company Quidel Corp (NASDAQ:QDEL) reported on Friday net income of USD14.9m (USD0.50 per diluted share) for the third quarter ended 30 September 2009.
This is an increase from USD4.7m (USD0.15 per diluted share) for the third quarter in 2008.
Total revenues of USD56.2m were generated for the third quarter of 2009, compared with USD31.9m for the third quarter of 2008, an increase of 76%. Sales of infectious disease products grew 91% year-on-year to USD47.0m, led by sales of the company's QuickVue Influenza products.
The gross margin increased to 69% from 62% in last year's third quarter.
Comments on this story may be sent to admin@m2.com
Tags: disease nasdaq products sales
Companies: QUIDEL Corp. (QDEL)
Oct 19, 2009 (Wall Street Horizon via COMTEX) --
Quidel Corporation (QDEL)
Expected next earnings release: Announcement date: 1/14/2010 - During Market Earnings Quarter: Q3 Announcement Status: Unconfirmed
Expected next investor conference call information: Conference Call Date: 10/19/2009 Conference Call Time (ET): 10:00 AM Conference Call URL: http://phx.corporate-ir.net/phoenix.zhtml?c=94060&p=irol-calendarPast
Tags: conference corporate earnings market
Companies: QUIDEL Corp. (QDEL)
Oct 18, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called an Uptrend for Quidel (NASDAQ:QDEL) on April 27, 2009 at $10.84.
Since then, Quidel has returned 47.3% as of Friday's recent price of $15.97. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq profit securities trial
Companies: QUIDEL Corp. (QDEL)
Total : 101 View more »
By Fain Hughes, fhughes@knobias.com Quidel Corporation (QDEL) issued a clarification on Friday regarding the Special 510(k) clearance for an update to the Company's QuickVue(R) Influenza A+B test package insert. A news wire agency released misleading information stating there is a new swine flu
We provide easy to use, rapid diagnostic solutions, on a worldwide basis. Our rapid tests are used to more effectively triage patients in acute care facilities and physicians offices.
Copyright © 2009 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
http://www.holdrs.com/holdrs/main/index.asp?Action=Headlines&Description=&Image=&symb=QDEL&sid=7469
The UrinQuick® Urine Chemistry Analyzer is a semi-automated benchtop instrument for the rapid analysis of urine test strips. The UrinQuick is designed to analyze and generate results for QuickVue® UrinChek® 10+ SG (Quidel Cat. No. 20104 and 20116) and QuickVue® UrinChek® 8+ (Quidel Cat. No.
Total : 22,800 View more »
Quidel Corporation Helping Women and Their Families Live Healthy Lives, discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for the detection of ...
Quidel Corporation Helping Women and Their Families Live Healthy Lives, discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for the detection of ...
Quidel Corporation Company Profile - View the latest news, market research, credit research, and investment research on Quidel Corporation San Diego CA United States http://www ...
http://www.alacrastore.com/company-snapshot/Quidel_Corporation-1011387
See the company profile for Quidel Corporation (QDEL) including business summary, industry/sector information, number of employees, business summary, corporate governance, key ...
The call will be hosted by Douglas C. Bryant, president and chief executive officer, and John M. Radak, chief financial officer of Quidel Corporation.